Interferons in relapsing remitting multiple sclerosis: a systematic review.
作者： Graziella Filippini , Luca Munari , Barbara Incorvaia , George C Ebers , Chris Polman
DOI: 10.1016/S0140-6736(03)12512-3
关键词:
摘要: … Interferons exert effects of potential relevance to multiple sclerosis: their antiviral action, and their pleiotropic effects on the immune system and blood-brain barrier, could benefit patients …
elsevier.com
sci-hub.se 
direct-ms.org 参考文章(42)
X Montalbán, T Arbizu, P de Castro, O Fernández, G Izquierdo, A Capdevíla, A Magalhaes, A Antiquëdad, J A García-Merino, J C Correa de Sa, Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial. Multiple Sclerosis Journal. ,(1995)
Systematic Reviews in Health Care BMJ Publishing Group. ,(2001) , 10.1002/9780470693926
LD Jacobs, DL Cookfair, RA Rudick, RM Herndon, J R Richert, AM Salazar, JS Fischer, DE Goodkin, CV Granger, JH Simon, LJ Emrich, DM Bartoszak, DN Bourdette, J Braiman, CM Brownscheidle, ME Coats, SL Cohan, DS Dougherty, RP Kinkel, MK Mass, FE Munschauer, RL Priore, PM Pullicino, BJ Scherokman, B Weinstock-Guttman, RH Whitham, A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). Multiple Sclerosis Journal. ,vol. 1, pp. 118- 135 ,(1995) , 10.1177/135245859500100210
Shah Ebrahim, Numbers Needed to Treat Derived from Meta‒Analyses: Pitfalls and Cautions Systematic Reviews in Health Care: Meta-Analysis in Context, Second Edition. pp. 386- 399 ,(2008) , 10.1002/9780470693926.CH20
Peter Jni, Douglas G Altman, Matthias Egger, Assessing the Quality of Randomised Controlled Trials John Wiley & Sons, Ltd. pp. 87- 108 ,(2008) , 10.1002/9780470693926.CH5
ROBERT L. KNOBLER, HILLEL S. PANITCH, SHERRY L. BRAHENY, JACK C. SIPE, GEORGE P. A. RICE, JOHN R. HUDDLESTONE, GORDON S. FRANCIS, CAROL J. HOOPER, ROBERTA M. KAMIN-LEWIS, KENNETH P. JOHNSON, MICHAEL B. A. OLDSTONE, THOMAS C. MERIGAN, Clinical trial of natural alpha interferon in multiple sclerosis. Annals of the New York Academy of Sciences. ,vol. 436, pp. 382- 388 ,(1984) , 10.1111/J.1749-6632.1984.TB14809.X
K. M. Myhr, T. Riise, F. E. G. Lilleas, T. G. Beiske, E. G. Celius, A. Edland, D. Jensen, J. P. Larsen, R. Nilsen, M. W. Nortvedt, A. I. Smievoll, C. Vedeler, H. I. Nyland, Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis Neurology. ,vol. 52, pp. 1049- 1049 ,(1999) , 10.1212/WNL.52.5.1049
ROBERT L. HIRSCH, KENNETH P. JOHNSON, The effects of long-term administration of recombinant alpha-2 interferon on lymphocyte subsets, proliferation, and suppressor cell function in multiple sclerosis. Journal of interferon research. ,vol. 6, pp. 171- 177 ,(1986) , 10.1089/JIR.1986.6.171
R. B Forbes, A. Lees, N. Waugh, R. J Swingler, Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis BMJ. ,vol. 319, pp. 1529- 1533 ,(1999) , 10.1136/BMJ.319.7224.1529
R. L. Knobler, H. S. Panitch, S. L. Braheny, J. C. Sipe, G.P.A. Rice, J. R. Huddlestone, G. S. Francis, C. J. Hooper, R. M. Kamin-Lewis, K. P. Johnson, M. B.A. Oldstone, T. C. Merigan, Systemic alpha‐interferon therapy of multiple sclerosis Neurology. ,vol. 34, pp. 1273- 1273 ,(1984) , 10.1212/WNL.34.10.1273